Pearl is the most widely-deployed dental AI imaging product, with FDA clearance for real-time radiograph review across multiple categories of pathology. The clinical-trust story is the strongest in the category — FDA clearance, peer-reviewed studies, and integrations with the major US practice-management systems. Pricing is per-practice subscription quoted on request, scaling with chair count. For multi-location DSOs and group practices it's effectively standard infrastructure now; for solo practitioners the cost-benefit is more individual.
Pearl's Second Opinion is an FDA-cleared AI platform that reviews dental radiographs in real time, surfacing detected pathology — caries, periapical lesions, calculus, bone level, and more — for the dentist's review during the patient visit.